Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA ruling upholds orphan drug exclusivity for Avonex

March 5, 1999

NMDA receptor antagonists potentiate opioid-induced analgesia in animals

March 4, 1999

Second-generation tetracyclines afford significant neuroprotection in stroke model

March 4, 1999

Dual 5-HT reuptake inhibitors/5-HT1A antagonists patented by Lundbeck

March 4, 1999

Mediolanum's AChE inhibitor falls by the wayside

March 4, 1999

ReQuip effective in restless legs syndrome

March 4, 1999

Biochemical and pharmacological profile of new MAO-A inhibitor: 2614W94

March 3, 1999

Alertec approved in Canada for treatment of narcolepsy

March 3, 1999

Janssen confirms lubeluzole no longer under development

March 3, 1999

FDA issues complete response letter for Rebif BLA

March 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.